
U.S. lawmakers question FTC's efforts to stop Illumina's deal for Grail
Two Republican lawmakers on Thursday questioned the Federal Trade Commission's efforts to unwind life science company Illumina Inc's $7.1 billion acquisition of Grail Inc , alleging the regulator was not following a normal path in its work.

- 1